LE LIEN NEWS FDA/NICOX POUR LE 12MAI ( partagé par Broker14)
Auj. à 15:21
US FDA TO HOLD MAY 12 PUBLIC MEETING OVER NICOX'S NONSTEROIDAL ANTI-INFLAMMATORY DRUG NAPROXCINOD
14:50 05Mar10 RTRS-US FDA TO HOLD MAY 12 PUBLIC MEETING OVER NICOX'S NONSTEROIDAL ANTI-INFLAMMATORY DRUG NAPROXCINOD
14:58 05Mar10 RTRS-BRIEF-NicOx faces May 12 FDA meeting for naproxcinod NSAID
WASHINGTON, March 5 (Reuters) - The U.S. Food and Drug Administration on Friday said: * The agency will hold a May 12 public meeting over NicOx SA's
nonsteroidal anti-inflammatory drug (NSAID) called naproxcinod to treat osteoarthritis * The FDA posted the announcement on its website at
http://www.federalregister.gov/OFRUpload/OFRData/2010-04813_PI.pdf
((Company news desk in Washington; +1 202 898 8400, washington.newsroom@thomsonreuters.com))
Pourquoi seul le Napro 375mmg est-il concerné ?
"Agenda: On May 12, 2010, the committees will discuss new drug application (NDA) 22478, naproxcinod0 375 milligram capsule, sponsored by NicOx S.A., a nonsteroidal anti-inflammatory drug (NSAID) product indicated for the treatment of the signs and symptoms of osteoarthritis."